CIBAR1P1: A Potential Drug Target and Biomarker (G729073)

Target Name: CIBAR1P1

NCBI ID: G729073

CIBAR1P1

Other Name(s): CIBAR1 pseudogene 1 | FAM92A1P1 | Family with sequence similarity 92 member A1 pseudogene 1 | Family with sequence similarity 92, member A2 (pseudogene) | FAM92A2

CIBAR1P1: A Potential Drug Target and Biomarker

CIBAR1 pseudogene 1 (CIBAR1P1) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The CIBAR1 gene is located on chromosome 1 and encodes for a protein known as CIBAR1P1. CIBAR1P1 has been shown to play a role in the development and progression of various diseases, including cancer, and has also been linked to an increased risk of cardiovascular disease.

Disease-Related Traits of CIBAR1P1

Studies have shown that CIBAR1P1 is involved in several disease-related traits, including cancer, cardiovascular disease, and neurodegenerative diseases. For example, studies have found that individuals with certain genetic variations in the CIBAR1P1 gene are at an increased risk of developing cancer, including breast and ovarian cancers. Additionally, CIBAR1P1 has been linked to an increased risk of cardiovascular disease, including heart failure, stroke, and high blood pressure.

Drug Target Potential

The potential drug target for CIBAR1P1 is based on its role in the development and progression of various diseases. Drugs that target CIBAR1P1 have the potential to treat diseases that are characterized by the over-expression or under-expression of CIBAR1P1. For example, drugs that inhibit the activity of CIBAR1P1 have been shown to have potential therapeutic benefits for various diseases, including cancer and neurodegenerative diseases.

Biomarker Potential

CIBAR1P1 has also been identified as a potential biomarker for several diseases. The expression of CIBAR1P1 has been shown to be associated with the progression of various diseases, including cancer and neurodegenerative diseases. Additionally, studies have shown that the expression of CIBAR1P1 is associated with poor prognosis in individuals with various diseases, including cancer.

Conclusion

In conclusion, CIBAR1P1 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer and cardiovascular disease. The over-expression or under-expression of CIBAR1P1 has been shown to play a role in the development and progression of these diseases, and drugs that target CIBAR1P1 have the potential to treat these diseases. Further research is needed to fully understand the role of CIBAR1P1 in disease and to develop effective treatments.

Protein Name: CIBAR1 Pseudogene 1

The "CIBAR1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CIBAR1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets